Results Of a Specified Clinical Trial On The Use of L. lactis strain Plasma For Patients With COVID-19
Nagasaki University presented the results of a specified clinical trial on patients with COVID-19 using Lactococcus. lactis strain Plasma, researched and developed by Kirin Holdings Company...[ read more ]